Jacopo Olivieri

1.4k total citations
24 papers, 374 citations indexed

About

Jacopo Olivieri is a scholar working on Hematology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Jacopo Olivieri has authored 24 papers receiving a total of 374 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 9 papers in Pathology and Forensic Medicine and 6 papers in Oncology. Recurrent topics in Jacopo Olivieri's work include Hematopoietic Stem Cell Transplantation (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Acute Myeloid Leukemia Research (4 papers). Jacopo Olivieri is often cited by papers focused on Hematopoietic Stem Cell Transplantation (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Acute Myeloid Leukemia Research (4 papers). Jacopo Olivieri collaborates with scholars based in Italy, United Kingdom and United States. Jacopo Olivieri's co-authors include Attilio Olivieri, Silvia Smaldone, Francesco Ramirez, Antonella Poloni, Sabrina Coluzzi, Armando Gabrielli, Pietro Leoni, Guido Gini, Pietro Leoni and Giorgia Mancini and has published in prestigious journals such as Blood, Medicine and British Journal of Haematology.

In The Last Decade

Jacopo Olivieri

22 papers receiving 371 citations

Peers

Countries citing papers authored by Jacopo Olivieri

Since Specialization

Citations

This map shows the geographic impact of Jacopo Olivieri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacopo Olivieri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacopo Olivieri more than expected).

Fields of papers citing papers by Jacopo Olivieri

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacopo Olivieri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacopo Olivieri. The network helps show where Jacopo Olivieri may publish in the future.

Co-authorship network of co-authors of Jacopo Olivieri

This figure shows the co-authorship network connecting the top 25 collaborators of Jacopo Olivieri. A scholar is included among the top collaborators of Jacopo Olivieri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacopo Olivieri. Jacopo Olivieri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Secondary primary malignancies after CD‐19 directed CAR‐T‐cell therapy in lymphomas: A report from the Italian CART‐SIE study 2024 ·British Journal of Haematology ·Angelica Barone, Annalisa Chiappella, Beatrice Casadei, Stéfania Bramanti, Silva Ljevar, Patrizia Chiusolo, Alice Di Rocco, Maria Chiara Tisi, Anna Maria Barbui, Mirko Farina, Lucia Brunello, (unknown), Mattia Novo, Maurizio Musso, Jacopo Olivieri, (unknown), Anna Dodero, Antonella Aiello, Paolo Corradini	3
2	Comparison of first-line treatment with bendamustine plus rituximab versus R-CHOP for patients with follicular lymphoma grade 3A: Results of a retrospective study from the Fondazione Italiana Linfomi 2023 ·Frontiers in Oncology ·(unknown), (unknown), Federica Cocito, (unknown), Luigi Petrucci, Maura Nicolosi, Ombretta Annibali, Carola Boccomini, Valentina Bozzoli, Alessia Castellino, Federica Cattina, (unknown), Sabino Ciavarella, Sofya Kovalchuk, Francesco Rotondo, Angelo Famà, Jacopo Olivieri, Francesco Zaja	0
3	Dental anxiety, cardiovascular changes and patient preconceptions toward implants and root canal treatments: An observational study 2022 ·Journal of Clinical and Experimental Dentistry ·(unknown), Jacopo Olivieri, (unknown), (unknown), Miguel Roig, Fernando Durán‐Sindreu	3
4	Rituximab and Bendamustine (BR) Compared with Rituximab, Bendamustine, and Cytarabine (R-BAC) in Previously Untreated Elderly Patients with Mantle Cell Lymphoma 2021 ·Cancers ·(unknown), Jacopo Olivieri, (unknown), (unknown), Rossella Paolini, Silvia Finotto, Roberto Sartori, Elisa Lucchini, (unknown), (unknown), Maria Chiara Tisi, (unknown), (unknown), Francesco Piazza, Isacco Ferrarini, Carlo Visco	8
5	Health-related quality of life in patients with acute promyelocytic leukemia: a systematic literature review 2021 ·Expert Review of Hematology ·Fabio Efficace, Laura Cannella, Massimo Breccia, Jacopo Olivieri, Uwe Platzbecker, Marco Vignetti	1
6	Nilotinib Treatment of Patients Affected by Chronic Graft-versus-Host Disease Reduces Collagen Production and Skin Fibrosis by Downmodulating the TGF-β and p-SMAD Pathway 2020 ·Biology of Blood and Marrow Transplantation ·(unknown), Andrea Costantini, Giorgia Mancini, Giovanni Tossetta, Jacopo Olivieri, Antonella Poloni, (unknown), Luca Butini, Anna Campanati, Gaia Goteri, Daniela Marzioni, Attilio Olivieri	35
7	A novel method to evaluate prethawing viability of cryopreserved CD34+ hematopoietic stem cells for autologous transplantation 2020 ·Transfusion ·(unknown), Andrea Costantini, Giorgia Mancini, (unknown), Jacopo Olivieri, (unknown), (unknown), (unknown), Luca Butini, Debora Capelli, Antonella Poloni, Attilio Olivieri	4
8	<i>SF3B1</i>-mutated chronic lymphocytic leukemia shows evidence of NOTCH1 pathway activation including CD20 downregulation 2020 ·Haematologica ·Federico Pozzo, Tamara Bittolo, Erika Tissino, (unknown), Elena Vendramini, Luca Laurenti, Giovanni D’Arena, Jacopo Olivieri, Gabriele Pozzato, Francesco Zaja, Annalisa Chiarenza, Francesco Di Raimondo, Antonella Zucchetto, Riccardo Bomben, Francesca Maria Rossi, Giovanni Del Poeta, Michele Dal Bo, Valter Gattei	13
9	Low-Dose Anti-T Lymphoglobulin as Prophylaxis for Graft-versus-Host Disease in Unrelated Donor Transplantations for Acute Leukemias and Myelodysplastic Syndromes 2018 ·Biology of Blood and Marrow Transplantation ·Francesca Bonifazi, Jacopo Olivieri, Mariarosaria Sessa, Elisa Dan, (unknown), Simonetta Rizzi, Maria Rosa Motta, Andrea Bontadini, (unknown), Valeria Giudice, Cristina Papayannidis, Antonio Curti, Angela Chiereghin, Tiziana Lazzarotto, Michèle Cavo, Mario Arpinati	6
10	Efficacy and toxicity of Decitabine in patients with acute myeloid leukemia (AML): A multicenter real-world experience 2018 ·Leukemia Research ·Carla Filì, Anna Candoni, Maria Elena Zannier, Jacopo Olivieri, Silvia Imbergamo, (unknown), Gianpaolo Nadali, Eros Di Bona, Anna Ermacora, Michele Gottardi, (unknown), Rosanna Ciancia, Davide Lazzarotto, (unknown), Gianluca Festini, Filíppo Gherlinzoni, Mariagrazia Michieli, Gianpietro Semenzato, Renato Fanin	26
11	Immunomodulatory Effects of Tyrosine Kinase Inhibitor In Vitro and In Vivo Study 2017 ·Biology of Blood and Marrow Transplantation ·(unknown), Andrea Costantini, (unknown), Benedetta Costantini, Jacopo Olivieri, Luca Butini, Giorgia Mancini, Ilaria Scortechini, Martina Chiarucci, (unknown), Antonella Poloni, Pietro Leoni, Attilio Olivieri	23
12	Modern Management of Anthracycline-Induced Cardiotoxicity in Lymphoma Patients: Low Occurrence of Cardiotoxicity with Comprehensive Assessment and Tailored Substitution by Nonpegylated Liposomal Doxorubicin 2017 ·The Oncologist ·Jacopo Olivieri, Gian Piero Perna, (unknown), (unknown), Attilio Olivieri, Pietro Leoni, Guido Gini	23
13	The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib 2016 ·Blood ·(unknown), Jacopo Olivieri, (unknown), Antonella Poloni, Giorgia Mancini, Francesco Saraceni, Anna Campanati, Gaia Goteri, Silvia Svegliati, Armando Gabrielli, Attilio Olivieri	1
14	Consensus recommendations for improvement of unmet clinical needs—the example of chronic graft-versus-host disease: a systematic review and meta-analysis 2015 ·The Lancet Haematology ·Jacopo Olivieri, (unknown), (unknown), Silvia Tedesco, Pietro Leoni, Armando Gabrielli, Alessandro Rambaldi, Andrea Bacigalupo, Attilio Olivieri, Giovanni Pomponio	10
15	A Combination of Lenalidomide and Rituximab (ReRi) As Salvage Therapy in Elderly Patients Affected By Diffuse Large B Cells (DLBCL) Lymphoma Relapsed and Refractory 2015 ·Blood ·Guido Gini, (unknown), Michela Sampaolo, Silvia Trappolini, (unknown), Jacopo Olivieri, Attilio Olivieri, Massimo Offidani, Serena Rupoli, Antonella Poloni, Anna Rita Scortechini, Debora Capelli, Mauro Montanari, Ilaria Scortechini, Pietro Leoni	4
16	Fatal Necrotizing Angiotropic Epstein–Barr Virus-negative Large B-cell Lymphoma 2014 ·Medicine ·Attilio Olivieri, Elena Sabattini, Gaia Goteri, Silvia Trappolini, Francesco Saraceni, (unknown), Guido Gini, Pietro Leoni, Jacopo Olivieri, Stefano Pileri	0
17	Kinetics of the use of cryopreserved autologous stem cell grafts: a GITMO-SIDEM survey 2013 ·Cytotherapy ·Jacopo Olivieri, Luca Pierelli, Martino Introna, Patrizia Accorsi, Alberto Bosi, Paolo Perseghin, Marco Risso, (unknown), Stefania Mancini, Monia Marchetti, Simone Dal Pozzo, Elisa Gotti, Alessandro Rambaldi, Pietro Leoni, Attilio Olivieri	3
18	Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA 2012 ·The Oncologist ·Attilio Olivieri, Guido Gini, (unknown), Mauro Montanari, Silvia Trappolini, Jacopo Olivieri, Marino Brunori, Massimo Catarini, (unknown), Alessandro Isidori, Francesco Alesiani, (unknown), (unknown), Giuseppe Visani, Antonella Poloni, Pietro Leoni	47
19	Ha-Ras stabilization mediates pro-fibrotic signals in dermal fibroblasts 2011 ·PubMed ·Silvia Smaldone, Jacopo Olivieri, G. Luca Gusella, Gianluca Moroncini, Armando Gabrielli, Francesco Ramirez	19
20	Fibrillin assemblies: extracellular determinants of tissue formation and fibrosis 2010 ·PubMed ·Jacopo Olivieri, Silvia Smaldone, Francesco Ramirez	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact